Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Global Markets Direct, September 2009, Pages: 69

Netherlands Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015

Summary

This report is an essential source for in-depth information and data relating to Netherlands drug delivery devices market. It also offers detailed and comprehensive coverage of market revenue, volume, distribution and company share information; and the latest news, financial deals and pipeline products information of each of the key sub-segments of the drug delivery devices market in Netherlands

Scope

- The report provides information on the drug delivery devices market in Netherlands.
- Details on the key segments and categories such as Inhalation Systems, Needle Free Injections, and Infusion Systems.
- Total revenues, products sold, end users, and average pricing.
- Market shares of all the key competitors such as AstraZeneca International plc, GlaxoSmithKline plc, Boehringer Ingelheim GmbH, Novartis AG, and Bespak plc.
- Key pipeline products that are set to shape the market, broken down by sector.
- Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
- Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
- Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
- Key mergers and acquisitions, partnerships, private equity investments and IPOs.
- Customer, hospitals and physicians data.

Reasons to buy

- Gain a strong understanding of the drug delivery devices market in Netherlands.
- Evaluate and compare the attractiveness of the market in the country.
- Identify growth segments and opportunities in each industry sector within the country.
- Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
- Analyze the competitiveness of the market in the country and identify hotspots.
- Develop strategies based on the latest product, brand, expansion and research and development news in the country.
- Plan deal strategies with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
- Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

1
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
3 Definitions of the Markets Covered in the Report
3.1 Drug Delivery Devices
3.2 Inhalation Systems
3.2.1 Metered Dose Inhaler
3.2.2 Dry Powder Inhaler
3.3 Infusion Systems
3.3.1 Infusion Pumps
3.3.2 Syringe Pumps
3.3.3 Disposable Infusion Sets
4 Healthcare Sector Review
4.1 Healthcare Expenditure
4.2 Healthcare Infrastructure
4.3 Healthcare Policy
4.3.1 Health Insurance Act
4.3.2 Healthcare Allowance Act
4.3.3 The Exceptional Medical Expenses Act
5 Regulation System
5.1 Medical Equipment Approval Process
5.1.1 Classification of Medical Devices
5.1.2 Conformity Assessment Process
5.1.2.1 Class I devices
5.1.2.2 Class IIa devices
5.1.2.3 Class IIb devices
5.1.2.4 Class III devices
5.2 Post Market Surveillance (PMS)
6 Pricing and Reimbursement
6.1 Pricing and Reimbursement in Netherlands
7 Distribution Structure
7.1 Distribution Structure in Netherlands
8 Drug Delivery Devices In Netherlands
8.1 Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), 2000-2015
8.2 Drug Delivery Devices, Netherlands, Category Volume (Units), 2000-2015
8.3 Drug Delivery Devices, Netherlands, Company Share (2007-2008)
9 Infusion Systems In Netherlands
9.1 Infusion Systems Overall Revenue (2000-2015)
9.2 Infusion Systems Overall Volume (2000-2015)
9.3 Infusion Systems Average Price (2000-2015)
9.4 Infusion Systems Distribution Share (2007-2008)
9.5 Infusion Systems, Netherlands, Company Share (2007-2008)
10 Inhalation Systems In Netherlands
10.1 Inhalation Systems Overall Revenue (2000-2015)
10.2 Inhalation Systems Overall Volume (2000-2015)
10.3 Inhalation Systems Average Price (2000-2015)
10.4 Inhalation Systems Distribution Share (2007-2008)
10.5 Inhalation Systems, Netherlands, Company Share (2007-2008)
11 Overview of Key Companies in Netherlands Drug Delivery Devices Market
11.1 Terumo Corporation
11.1.1 Company Overview
11.2 Smiths Medical
11.2.1 Company Overview
11.3 Novartis AG
11.3.1 Company Overview
11.4 Hospira, Inc.
11.4.1 Company Overview
11.5 GlaxoSmithKline plc
11.5.1 Company Overview
11.6 Fresenius Kabi AG
11.6.1 Company Overview
11.7 Cardinal Health, Inc.
11.7.1 Company Overview
11.8 Boehringer Ingelheim GmbH
11.8.1 Company Overview
11.9 Consort Medical plc
11.9.1 Company Overview
11.9.2 Bespak plc Pipeline Products
11.9.2.1 Bespak plc Pipeline Products By Equipment Type
11.9.2.2 Bespak plc Pipeline Products By Development Stage
11.9.2.3 Bespak plc Pipeline Products By Therapy Area
11.10 Baxter International Inc.
11.10.1 Company Overview
11.11 B. Braun Melsungen AG
11.11.1 Company Overview
11.12 AstraZeneca PLC
11.12.1 Company Overview
11.13 Medisize B.V.
11.13.1 Company Overview
12 Recent Developments
12.1 Strategy And Business Planning
12.1.1 Jan 28, 2009: Philips Leads European ‘SonoDrugs’ Project To Develop Image-Guided Localized Drug Delivery Technologies
12.2 Product News
12.2.1 Jun 15, 2007: OptiNose Announces The Initiation Of Phase II Study In Chronic Rhinosinusitis
13 Appendix
13.1 Global Markets Direct Research Methodology
13.2 Secondary Research
13.3 Primary Research
13.4 Models
13.5 Forecasts
13.6 Expert Panel Validation
13.7 Currency Conversion
13.8 Contact Us
13.9 Disclaimer

Executive Summary

1.1 List of Tables
Table 1: Healthcare Expenditure in Netherlands, 2000 - 2007 12
Table 2: Doctors by Specialty in Netherlands, 2000-2006 16
Table 3: Hospital Wards by Type in Netherlands, 2000-2006 17
Table 4: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), 2000-2015 34
Table 5: Drug Delivery Devices, Netherlands, Cross-Category Analysis, 2000-2015 35
Table 6: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Historic, 2000-2008 36
Table 7: Drug Delivery Devices, Netherlands, Overall Revenue ($ mn), Forecast, 2008-2015 37
Table 8: Drug Delivery Devices, Netherlands, Category Volume (Units), 2000-2015 38
Table 9: Drug Delivery Devices, Netherlands, Category Volume (Units), Historic, 2000-2008 39
Table 10: Drug Delivery Devices, Netherlands, Category Volume (Units), Forecast, 2008-2015 40
Table 11: Drug Delivery Devices, Netherlands, Company Share by Revenue ($ mn), 2007-2008 41
Table 12: Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 42
Table 13: Infusion Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015 43
Table 14: Infusion Systems, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 44
Table 15: Infusion Systems, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 44
Table 16: Infusion Systems, Netherlands, Average Price ($), Historic, 2000-2008 45
Table 17: Infusion Systems, Netherlands, Average Price ($), Forecast, 2008-2015 45
Table 18: Infusion Systems, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 46
Table 19: Infusion Systems, Netherlands, Company Share by Revenue ($ mn), 2007-2008 47
Table 20: Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Historic, 2000-2008 48
Table 21: Inhalation Systems, Netherlands, Revenue ($ mn) by Segment, Forecast, 2008-2015 49
Table 22: Inhalation Systems, Netherlands, Volume (Units) by Segment, Historic, 2000-2008 50
Table 23: Inhalation Systems, Netherlands, Volume (Units) by Segment, Forecast, 2008-2015 51
Table 24: Inhalation Systems, Netherlands, Average Price ($), Historic, 2000-2008 52
Table 25: Inhalation Systems, Netherlands, Average Price ($), Forecast, 2008-2015 52
Table 26: Inhalation Systems, Netherlands, Distribution Share by Revenue ($mn), 2007-2008 53
Table 27: Inhalation Systems, Netherlands, Company Share by Revenue ($ mn), 2007-2008 54
Table 28: Bespak plc Pipeline Products by Equipment Type 60
Table 29: Bespak plc Pipeline Products By Development Stage 60
Table 30: Bespak plc Pipeline Products By Therapy Area 60
Table 31: USD to Local Currency, Average Exchange Rate 2008 68

Terumo Corporation
Smiths Medical
Novartis AG
Hospira, Inc.
GlaxoSmithKline plc
Fresenius Kabi AG
Cardinal Health, Inc.
Boehringer Ingelheim GmbH
Consort Medical plc
Baxter International Inc.
B. Braun Melsungen AG
AstraZeneca PLC
Medisize B.V.

Customers who bought this item also bought

• Healthcare, Regulatory and Reimbursement Landscape - The Netherlands
• Netherlands Pharmaceuticals and Healthcare Report Q2 2013
• Taiwan Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
• OTC Distribution in Europe: Entering a new Era - New Expanded 2012 Edition
• Netherlands Pharmaceuticals and Healthcare Report Q4 2011
• Netherlands Pharmaceuticals and Healthcare Report Q3 2012
• Spain Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
• France Drug Delivery Devices Investment Opportunities, Analysis and Forecasts to 2015
• Netherlands Pharmaceuticals and Healthcare Report Q4 2012
• Netherlands Pharmaceutical Market Analysis, 2010-2014